MAPT and Alzheimer disease: On the other hand, modulating tau pathology of AD seems to be more controllable than Aβ pathology because tau pathology appears later than Aβ pathology and continues to expand during devastating disease progression with neuronal loss and cognitive impairment, once diagnosed as AD.3